The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

NCT05238363 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Henlius Biotech